StartUp Health’s recent funding report placed Q2 2017 as one of the biggest quarters of all time, and MobiHealthNews’s own data seems to back up that claim. During the quarter, we tracked 81 deals, totaling $2.58 billion. Read on for the full list of companies that raised equity from investors over the last three months, and click the links to check out the full story. We’ve ranked them in order from largest to smallest, with undisclosed rounds at the end.
Outcome Health — $500 million. Outcome Health, a maker of waiting room screens and tablets for patient education and pharmaceutical marketing, raised at least $500 million in first round funding, lending the company a valuation of around $5 billion. Goldman Sachs Investment Partners, Alphabet’s growth equity investment fund CapitalG, Leerink Transformation Partners, Pritzker Group Venture Capital, and Balyasny Asset Management are a few of the many investors in the round, along with some undisclosed strategic investors that include health systems and other stakeholders.
Peloton — $325 million. Peloton, the New York City-based technology company that has seen impressive success combining exercise bikes with tablets to create virtual cycling classes, raised $325 million in late stage funding. The investment brought the company’s total funding to nearly $445 million and brought its valuation to $1.25 billion. Wellington Management, Fidelity Investments, Kleiner Perkins, and True Ventures led the round, with additional contributions from Comcast NBCUniversal, GGV Capital, Balyasny, and QuestMark.
Modernizing Medicine — $231 million. Modernizing Medicine, which makes a mobile-based EHR for specialists, raised $231 million from global private equity firm Warburg Pincus. The company has raised funding a number of times before, so this raise took its total funding to $318 million.
Bright Health — $160 million. Bright Health, the Minnesota-based health insurance startup that boasts “a smarter, more connected” experience, raised a new round of $160 million. Greenspring Associates led the round, with additional participation from new investors Greycroft Partners, Redpoint Ventures and Cross Creek Advisors and existing investors New Enterprise Associates (NEA), Bessemer Venture Partners, and Flare Capital Partners. The raise followed an $80 million round from Bright Health in April of last year, bringing the company’s total funding to $240 million.
Patient Point — $140 million. PatientPoint, the Cincinnati, Ohio-based company that makes education and engagement platforms for patients and providers, raised $140 million in new funding from Searchlight Capital Partners and Silver Point Capital. The company – which provides content through a variety of delivery methods including digital waiting rooms and interactive touchscreens in exam rooms – plans to use the latest funding to expand its already considerably large digital footprint.
Clover Health — $130 million. Clover Health, an insurance startup with a patient engagement bent, raised $130 million in a round led by existing investor Greenoaks Capital Management. New investors Google Ventures, Palm Drive Capital, and Western Technology Investment and existing investors Sequoia Capital and First Round Capital also contributed.
Blink Health — $90 million. New York City-based startup Blink Health, which makes an app and online tool to help consumers find low prices on medications, raised $90 million in Series B funding in a round led by 8VC. Previously, the company raised $75 million – also led by 8VC – bringing the company’s total funding to date at $165 million.
Sharecare — $85 million. Atlanta, Georgia-based Sharecare, a wellness and patient engagement company known for its serial acquisitions, received an investment from Summit Partners that brings the company’s total funding to $300 million. Given the company’s previous funding, Crunchbase pegged the May funding raise at $85 million. Sharecare will use the latest capital to expand their workforce and invest in new strategies to continue growing.
Outset Medical — $76.5 million. Outset Medical, a startup focused on innovating the practice of kidney dialysis, raised $76.5 million in a series C round led by T. Rowe Price Associates. In addition to new investor T. Rowe Price Associates, existing investors Fidelity Management & Research Company, Partner Fund Management LP, Warburg Pincus, Perceptive Advisors and The Vertical Group also participated. This round of funding brings the company’s total funds raised to $185.5 million.
ClassPass — $70 million. New York-based ClassPass, a virtual fitness membership network, raised $70 million in Series C funding in a round led by Temasek. Existing investors Acequia Capital, CRV, General Catalyst, GV, M13 and Thrive also contributed to the funding, which ClassPass will use to expand operations and develop new products.
babylon — $60 million. UK-based health chatbot company babylon, which raised $25 million in early 2016, raised an additional $60 million in April. While the company didn’t disclose the investors, the round reportedly included Sawiris, an Egyptian billionaire business family, NNS holdings, Vostok New Ventures, and existing backers Kinnevik.
Omada Health — $50 million. San Francisco-based Omada Health raised $50 million in new funding, led by commercial partner Cigna. Civilization Ventures and Sanofi Genzyme BioVentures also contributed to the round. Omada last raised money in September 2015, when it took in $48 million. This latest round brings the company’s total funding to $127.5 million.
Glooko — $35 million. Diabetes data management company Glooko raised $35 million in new funding. The company already had strategic investments from Samsung and Medtronic; in this new round the Mayo Clinic and insulin pump maker Insulet join those ranks. Toronto-based Georgian Partners led the round, with participation from existing investors Canaan Partners and Social Capital, in addition to the aforementioned health and tech stakeholders.
VitalConnect — $33 million. San Jose, California-based VitalConnect, a maker of wearable sensors for remote monitoring, raised $33 million in Series C financing in a round led by MVM Life Science Partners and Baxter International. The company, which last raised money in June 2016, plans to use the funding to move forward with commercializing its remote monitoring platform and medical-grade wearable sensor system.
Medrio — $30 million. Clinical trial software company Medrio raised $30 million in new funding from Questa Capital Management. This is the first ever institutional funding round for the 12-year-old company, and will be used to support growth as well as the development of new software programs.
PolicyGenius — $30 million. PolicyGenius, which makes a virtual insurance marketplace platform, raised $30 million in Series C funding in a round led by Norwest Venture Partners, bringing the company’s total funding to $52 million. The company, which works with payers to establish a quoting engine that allows shoppers to do side-by-side comparisons of policies, started its business looking at life insurance, then expanded to health, renter’s, disability and pet insurance.
Science 37 — $29 million. Remote clinical trial company Science 37 raised $29 million in a round led by Glynn Capital Management with participation from Google’s investment arm GV. One more new investor, AmGen Ventures, contributed, as did existing investors Lux Capital, Redmile Group, dRx Capital, and Sanofi Ventures. The round brings the company’s total funding to $67 million.
Amino — $25 million. San Francisco-based Amino, which offers an online healthcare marketplace platform, raised $25 million in Series C funding. Highland Capital Management led the round, with Accel, Aspect Ventures, CRV, Northwestern Mutual Future Ventures, Pilot Wall Group, and others contributing. Previously, the company raised a little over $19 million, and this new investment brings Amino’s total funding to date to nearly $45 million.
ZappRx — $25 million. Digital specialty prescribing platform ZappRx raised $25 million in Series B funding in a round led by Qiming US Healthcare Fund. GV, formerly Google Ventures, and SR One also contributed funding. The added capital will be used to expand ZappRx’s workforce as the company explores greater adoption from providers and other partners.
TwoPoreGuys — $24.5 million. Santa Cruz, California-based Two Pore Guys, which is developing a novel method of diagnostic testing via a device that digitally detects molecules, raised $24.5 million in a round led by Khosla Ventures. Two Pore Guys (aka 2PG) will use the funding to scale up the manufacturing of its hand-held device.
Kry — $22.6 million. Stockholm, Sweden-based Kry, purveyors of an app-based telemedicine service, closed on almost $22.6 million in Series A funding led by Silicon Valley venture firm Accel Partners. Index Ventures, Creandum and Project A also returned to contribute to financing. The company received $6.8 million in seed funding August 2016, and the latest funding brings Kry’s total capital to date to $29.4 million.
Capsule — $20 million. Pharmacy startup Capsule, which hand delivers drugs in New York City, raised $20 million in a round led by Thrive Capital, with contribution from Sound Ventures and Virgin Group. The company is working to establish itself apart from other such virtual pharmacies like Blink Health and PillPack, as well as the behemoth pharmacy benefits manager Express Scripts.
Art Medical — $20 million. Israel and Palo Alto-based Art Medical, a developer of smart intubation devices for use in intensive care, raised $20 million in a round led by Advanced Medical Technologies. Founded in 2009, Art Medical previously raised $7 million from a combination of funding from the Israel Innovation Authority and Bill Gates’ Grand Challenge. In the eight years since founding, the company has been working on a suite of connected, sensor-laden tubes to continuously monitor for complications and collect data of patients in the ICU.
Trice Medical — $19.3 million. Trice Medical, which has developed a tiny, needle-based camera to triage joint injuries rather than doing so with a traditional MRI, raised $19.3 million in Series C funding to take the device’s reach further into the US market. Safeguard Scientificis, HealthQuest Capital, BioStar Ventures and Smith & Nephew contributed, bringing Trice’s total funding to date at $40.9 million.
DayTwo — $17 million. DayTwo, an Israeli startup focused on delivering insights to consumers based on their gut microbiome, raised $12 million from an impressive suite of investors including Johnson & Johnson Innovation and the Mayo Clinic. Seventure Partners’ Health for Life Capital Fund also contributed along with private investors including cofounder Marius Nacht.
DocPlanner — $16.8 million. DocPlanner, a Polish appointment booking software company, raised $16.8 million (15 million euro) in new funding from Enern Investments, Target Global, and One Peak Partners. Existing investors Enern and Target Global led the round. This brings the company’s total funding to $51 million (46 million euros).
ChartSpan — $16 million. Greenville, South Carolina-based ChartSpan Medical Technologies, which makes digital care coordination tools, raised $16 million in a round led by Cypress Growth Capital. ChartSpan’s platform runs the gamut of practice management software, mobile patient engagement and records management tools. The turn-key service is available to health systems and ambulatory practices throughout the country, enabling them to provide out-of-office healthcare services to their patients.
RapidSOS — $14 million. RapidSOS, a 4-year-old startup with roots at Harvard and MIT, raised $14 million to bring 911 and other first responder networks into the smartphone age. Highland Capital Partners led the round, with participation from A3 Ventures, The Westly Group, Two Sigma Ventures, Motorola Solutions Venture Capital and Responder Ventures. Former FCC Chairs Tom Wheeler, Julius Genachowski, and Dennis Patrick also contributed along with other undisclosed individuals.
Mindstrong Health — $14 million. Mindstrong Health, the mental health startup that former NIMH director Dr. Thomas Insel left Verily for last month, raised $14 million. Foresite Capital and ARCH Venture Partners led the round, with additional participation from Optum Ventures, Berggruen Holdings, and the One Mind Brain Health Impact Fund.
Drchrono — $12 million. Mobile EHR drchrono raised $12 million in new funding in a round led by Runa Capital. Maxfield Capital, Eric Dunn (CEO of Quicken Inc. and Intuit’s first CTO), and FundersClub also participated in the round. The company is raising money in order to be more competitive with larger EHRs and also has plans to build more iOS apps and continue its work with Apple as a mobility partner.
ClearDATA — $12 million. Austin, Texas-based ClearDATA, a cloud services provider that exclusively serves the healthcare and life sciences market, raised $12 million from a stable of existing investors including Merck Global Health Innovation Fund, Norwest Venture Partners, Excel Venture Management, Heritage Group, HLM Venture Partners, and Flare Capital Partners. This round brings ClearDATA’s total funding to $55 million.
Aira — $12 million. San Diego-based Aira raised $12 million to continue developing its smart glasses that combine AI and remote human agents to help blind and low-vision people navigate the world. JAZZ Venture Partners and Arboretum Ventures led the round and existing investors Lux Capital, ARCH Venture Partners and Felicis Ventures participated. The National Federation of the Blind joined the round as a strategic investor. The round brings the company’s total funding to about $15 million.
Doc Halo — $11 million. Cincinnati, Ohio-based clinical communications provider Doc Halo raised $11 million in a series A round led by Bane Capital Ventures. Cincinnati-based Refinery Ventures also contributed to the round. Doc Halo has been operating for seven years in the clinical comms space, but this was its first outside funding round; cofounders Dr. Jose Barreau and Dr. Amit Gupta, both former practicing physicians, self-funded the company initially with $5 million of their own money.
Lemonaid Health — $11 million. San Francisco-based Lemonaid Health, which offers a simple, text-based telemedicine app, raised $11 million in Series A funding. Novartis Venture Fund and Hikma Ventures led the round, with participation from Correlation Ventures, Adaptive Healthcare Fund, Vega Ventures and 415 Ventures. The company last received funding in 2015, and the latest investment brings Lemonaid’s total capital to date to around $20 million.
Evidation Health — $10 million. San Mateo, California-based Evidation Health, which was launched last year by GE Ventures and Stanford Healthcare, raised $10 million from Sanofi-Genzyme BioVentures. GE Ventures and B Capital were return investors, and both firms participated in the efficacy-focused company’s $3.4 million round in October 2016. The latest investment brings the company’s total funding to at least $31 million.
Figure 1 — $10 million. Clinical image and knowledge-sharing app Figure 1, which is sometimes described as an Instagram for doctors, raised $10 million in funding in a round led by Kensington Capital Partners, with additional support from Samsung NEXT Ventures, John Hancock/Manulife Financial, Hedgewood, and WTI. Existing investors Union Square Ventures, Rho Canada Ventures, and Version One Ventures also participated.
Your.MD — $10 million. London-based medical chatbot company Your.MD raised $10 million in a round led by Orkla Ventures, the venture arm of consumer goods company Orkla. Existing investor Smedvig Capital also participated in the round. Your.MD last raised funds in 2015; this round brings the company’s total funding to $17.3 million.
Xealth — $8.5 million. Xealth, a spin-out from Providence St. Joseph Health’s digital innovation group that helps doctors to prescribe digital health apps, raised $8.5 million in a round led by DFJ Venture Partners. Other investors in the round included hospital systems Providence St. Joseph Health, University of Pittsburgh Medical Center (UPMC), Hennepin Healthcare System, and Froedtert Health.
HealthLoop – $8.4 million. Mountain View, California-based HealthLoop, which offers a platform to connect patients with their care team between visits, has raised $8.4 million from iCarbonX DigitalLife Alliance, NextEquity, Lafayette General Hospital through its Health Innovation Fund, Canvas Ventures, and Summation Health Ventures. HealthLoop has been quietly getting into hospitals around the country over the last few years including Cleveland Clinic and Kaiser Permanente-Southern California. Last summer HealthLoop announced a deployment at Memorial Sloan Kettering Cancer Center’s Josie Robertson Surgery Center.
Artemis Health – $8.3 million. The Salt Lake City, Utah-based maker of data analytics tools for employee benefit managers, raised $8.3 million in a round led by Maverick Ventures. In addition to the funding, the company added two new members to its board: Ashok Subramanian, former co-founder and CEO of Liazon and the head of the Group Exchange business at Willis Towers Watson, and Ambar Bhattacharyya, managing director at Maverick Ventures.
Simple Contacts – $8 million. Simple Contacts, a New York City-based ocular telemedicine company, raised $8 million in its second round of funding. The round was led by Goodwater Capital with participation from existing investors Justin Kan, Notation Capital, and Autonomous Ventures. The company plans to use the new funding to expand its product and marketing teams, to both improve the product and bring it into more markets.
Conversa – $8 million. San Francisco-based Conversa, makers of a healthcare conversation platform, raised $8 million in Series A funding to expand its product offerings and build up its clinical conversation library. Northwell Ventures, the funding arm of New York healthcare system Northwell Health, led the round, with contribution from Epic Ventures and Healthgrades.
Viz – $7.5 million. San Francisco-based Viz looking to apply artificial intelligence to medical imaging, and raised $7.5 million in first-round funding. The funding round was led by DHVC and Alphabet Chairman Eric Schmidt’s Innovation Endeavors. AME Cloud Ventures and Susa Ventures also contributed. Viz is initially focusing on stroke, but intends to expand its capability to a number of health conditions where diagnostic imagery is used and time is of the essence.
AiDoc – $7M. Flush with a new $7 million in funding led by Tel Aviv VC firm TLV Partners, AiDoc is working to take its artificial intelligence-powered medical imaging tool into clinics to help radiologists work through their case load faster. The company has built deep learning algorithms to analyze imaging and clinical data quickly, enabling it to scan for visual abnormalities in medical scans.
CirrusMD – $7 million. Denver-based telemedicine startup CirrusMD, which focuses on a text-first approach to virtual visits for large health systems and payers, closed on $7 million in Series A funding led by Colorado Impact Fund. Since the company’s founding five years ago, CirrusMD lists 1.3 million patients with access to the platform, which represents an 850 percent growth since last year. With the latest funding, the company plans to expand sales, marketing, customer support resources and further innovate on their platform and data analytics.
Digital Pharmacist – $6.5 million. Austin-based Digital Pharmacist, a company that offers prescription management apps, has raised $6.5 million in new funding in a round led by Activate Venture Partners and LiveOak Venture Partners. The company, which was formed in January from a merger of RxWiki and Telemanager, has raised $13.7 million to date.
Solv – $6.25 million. San Francisco-based Solv Health, which is developing an app that allows people to find and book same-day doctor’s appointments at urgent care clinics, has raised $6.25 million in Series A funding. The investment round was led by Benchmark Capital with participation from Theresia Gouw of Aspect Ventures and Malay Gandhi of Ensemble Labs (Gandhi is also the former CEO of seed fund Rock Health). The new funding will be used to expand testing to more users around the state, and Benchmark Capital’s General Partner Bill Gurley will join Solv’s board of directors.
LogicStream Health – $6 million. The Minneapolis company whose software uses EHR data to help hospitals maximize workflow efficiency raised $6 million in a new round of funding led by Noro-Moseley Partners. Some existing investors also contributed. LogicStream will pour the new funds into product development as well as expanding sales and marketing teams to meet what the company says is a growing demand for the software.
Upfront Healthcare Services – $5.6 million. Chicago-based Upfront Healthcare Services – which offers a data analytics platform to help large physician practices ascertain how best to schedule and allocate resources –raised $5.6 million in Series A funding. The round was led by Nashville Capital Network, with contribution from Echo Health Ventures, Hyde Park Venture Partners and Martin Ventures.
Vericred – $5.5 million. Healthcare data company Vericred, which offers a platform with provider-network dataset, raised $5.5 million in a round led by FCA Venture Partners. The company, whose centralized data platform allows individuals and business to enroll, understand and use health insurance and employee benefits, has raised nearly $10 million to date.
Spry Health – $5.5 million. Palo Alto-based Spry Health raised $5.5 million in funding led by Grove Ventures and Stanford StartXFund to commercialize Loop, a wearable wristband and remote patient monitoring platform for people with chronic illnesses.
Sansoro Health – $5.2 million. Sansoro Health, a company that connects digital health technologies with electronic health records, raised $5.2 million. Bain Capital Ventures led the round. Combined with last year’s $1.2 million raise from Healthy Ventures and Treehouse Ventures, the company’s total funding is now at $6.4 million. The company has been around for about two years and in that time has deployed its platform at 20 healthcare organizations. The new funding will be used to expand sales and marketing operations.
Savonix – $5.1 million. San Francisco-based Savonix, maker of an app for neurocognitive assessment, raised $5.1 million in a new round of funding. DigiTx Partners led the round with additional contribution from ReThink Impact. Savonix will use the new funding to expand into new international markets including China and Japan. The company also plans to develop additional partnerships and to hire more data scientists and product developers. Dr. David Kim, CEO at DigiTx Partners, and Heidi Patel, Partner at ReThink Impact, will join Savonix’s Board of Directors.
FitnessGenes – $5 million. London-based FitnessGenes, which creates personalized fitness and nutrition plans for individuals based on a the results of an at-home DNA testing kit, raised $5 million. Sino-German High Tech Fund (SGHF), an investment fund comprised of China’s Donghai Securities and Germany’s Grunderfonds, led the round. The company – which was founded by doctors from the University of Oxford and Birmingham in 2013 and also operates under the name MuscleGenes – is working to add another $5 million in funding to close out the Series A and plans to use the capital to advance their platform and product offering as well as expand operations in North America and Europe.
Doc+ – $5 million. Doc+, a Russian digital health company that combines telemedicine with digital-enabled house calls, raised $5 million from two existing investors: Yandex, an internet services company, and Baring Vostok venture fund. This is the second round of funding and brings Doc+’s total funding to $10.5 million. The company’s primary business is digital-enabled house calls, similar to US companies like Heal and Pager. The visits are currently available in Moscow and Saint Petersburg, and the company has plans to add a third Russian city soon.
Mpirica – $4.6 million. Seattle-based healthcare quality transparency company Mpirica has raised $4.6 million in a round led by equity crowdfunding platform OurCrowd. With its team of data scientists and physicians, Mpirica uses claims data to rate surgeons based on its own proprietary methods. Three-digit quality scores, modeled after FICO credit scores, are available online for 864 different surgical procedures.The company plans to use the funding to support a national rollout to Medicare Advantage customers.
Murj – $4.5 million. Santa Cruz, California-based Murj, developer of a digital data collection platform for implantable cardiac devices, has officially emerged from stealth mode. Backed by $4.5 million in venture funding, the company wants to streamline workflow for clinicians grappling with increasingly more data from heart-monitoring devices, both remotely and in the office.
PreparedHealth – $4 million. Chicago-based Prepared Health, which makes a care coordination platform focused on aging-in-place populations, raised $4 million in seed funding in a round led by Chicago Ventures. Pritzker Group Venture Capital, Beverly Capital and Meridian Street Capital also contributed. The company will use the new funding to invest in R&D and enter new markets.
Saranas – $ 4 million. Houston, Texas-based medical device company Saranas raised $4M to support continued development on their sensor-enabled bleeding detection device intended for use during cardiac procedures. The device is still in the product testing phase, and Saranas plans to submit for FDA clearance later this year.
Cocoon Cam – $4 million. Silicon Valley-based Cocoon Cam raised $4 million in Series A led by Happiness Ventures. Previously, the company raised a little more than $1 million, and will use the latest investment continue developing, marketing and selling their smart video camera-based baby monitor.
Gixo – $3.7 million. Backed by $3.7 million in funding led by Greylock Partners, San Francisco-based fitness app company Gixo officially launched its subscription-based live workout app to Android and iOS in May. Cowboy Ventures and xSeed Capital also contributed funding to the round.
Devicare – $3.3 million. Barcelona, Spain-based Devicare, which is developing remote patient monitoring devices for people with chronic conditions, raised nearly $3.3 million (3 million euros) in seed funding. Investment holding company Emesa Coporacion Empresarial and several family and corporate partners contributed to the round. The company has raised $4.9 million (4.5 million euros) since its founding in 2012.Devicare will use the funding to launch clinical studies for two of their main products in Spain.
Lybrate – $3 million. Indian startup Lybrate, which helps patients in its home country connect to doctors – both in person and by telemedicine – raised another $3 million in a round with undisclosed investors. The company now has $15 million in investment funding. As TechCrunch points out, Lybrate is a direct competitor with Practo, which has raised $180 million, more than 10 times as much.
ReThink Medical – $3 million. San Francisco-based ReThink Medical raised $3 million to develop a medical wearable to predict and prevent heart failure. The round was led by Emergent Medical with additional funding from Norwich Ventures and Launch Capital. The company is also operating with a previously-awarded NIH grant as well as a strategic partnership with Japanese medical device company Terumo Corporation, which includes an investment.
TuringSense – $3 million. TuringSense, which is developing interactive wearables for sports and physical therapy, raised $3 million in a new round of funding. The company also raised $3 million in its first round two years ago. The newest round was led by VC firm and returning investor Ideosource, with participation from new investors The Core Group and Fenox Venture Capital.
Catalia Health – $2.5 million. Catalia Health, which makes an AI-powered patient engagement robot called Mabu, raised $2.5 million in a new round led by Khosla Ventures. Additional investments came from new investors NewGen Capital and Macnica Ventures and existing investors Q Venture Partners Limited, InnoLinks Ventures, Abstract by Flight.VC, DeNA and Lucky Capital. This brings the company’s total funding to $3.75 million.
DBS System – $2.5 million. This Swiss company that makes a line of portable blood tests called HemaXis raised $2.5 million led by investiere. (The funding was in Swiss francs, but the values of the currencies are currently approximately equal). The company’s method, called microsampling, requires considerably less blood than existing blood tests. The funds raised are going to the development of a second-generation device called HemaXis DP, which will be able to passively separate plasma from serum without the need for centrifugation or filtration.
Simple Habit – $2.5 million. San Francisco-based meditation app Simple Habit raised $2.5 million in a new round of funding that includes investors New Enterprise Associates (NEA), Fabrice Grinda’s FJ Labs, Foundation Capital and the founders of Dropbox and Gusto. This is the first round of funding for the company, whose app launched on the iOS App Store in April 2016.
Scorpio Labs – $2.5 million. Israeli equity crowdfunding platform OurCrowd invested $2.5 million in digital microscopy and diagnostics company Scopio Labs, which is the 23rd health technology company to receive funding from investor.
BioDirection – $2 million. Medical device company BioDirection raised $2 million in interim funding to develop their point-of-care products intended for diagnoses and management of concussions and other traumatic brain injuries. Their first product, called the Tbit System, uses the company’s nanotechnology biosensor to detect and measure protein biomarkers that the brain releases immediately after head trauma. With the portable system, BioDirection aims to make earlier diagnosis and treatment without the need for CT scans.
EverlyWell – $2 million. Austin, Texas-based EverlyWell, maker of a digital platform that lets consumers to order lab tests online, provide samples and receive results, raised another $2 million in a round led by Next Gen Venture Partners. Jack Novak, SoGal Ventures, Full Tilt Capital and other unnamed venture capital firms contributed. Last year, EverlyWell raised $2.5 million, and also had $500,000 in seed funding, which brings the company’s total funding to date to $5 million. EverlyWell plans to use the latest funding to hire more leadership positions, explore new partnerships and improve their product features.
eVisit – $2 million. Arizona-based telemedicine platform provider eVisit raised $2 million from Kickstart Seed Fund, Arizona Founders Fund and angel investor Jeremy Andrus. Previously, the company raised $1 million in July 2016. The latest funding will be used to scale eVisit’s sales, marketing and support teams as they expand.
NowRx – $2 million. Mountain View, California-based NowRx, an app-based pharmacy delivery company, raised $2 million in seed funding. The startup, which has been in operation a little over a year, plans to use the capital to expand their customer base.
Osso VR – $2 million. Osso VR, a startup looking to disrupt the surgical device training space with virtual reality, raised $2 million in seed funding in a round led by Signalfire, with participation from Anorak Ventures.
Thriva – $1.9 million. London-based mail order consumer blood testing startup Thriva raised $1.9 million (1.5 million pounds) in a round of seed funding. Individual investors include Zoopla CEO Alex Chesterman and TransferWise CEO Taavet Hinrikus and funds investing include Seedcamp, 500 Startups and the London Co-Investment Fund (LCIF).
Spring – $1.5 million. New York City-based Spring, which offers clinical decision support for providers around behavioral health, raised $1.5 million in seed funding. William K. Warren Foundation, a philanthropic organization associated with the St. Francis Health System, and serial entrepreneur Kevin Ryan (founder of Gilt and Business Insider) led the round. Additional contributions came from RRE Ventures, North Sound Ventures, Saddlefire Ventures, and Rough Draft Ventures. Spring is commercializing technology that was originally developed at the Yale School of Psychiatry, which has been clinically validated in studies published in JAMA Psychiatry and Lancet Psychiatry.
BrainCheck – $1.5 million. Houston-based BrainCheck, developer of a mobile neurocognitive assessment platform, raised $1.5 million to expand sales, distribution channels, and research opportunities for its product. True Wealth Ventures led the latest round, which, together with the company’s previous raise of $3 million, brings BrainCheck’s total to $4.5 million.
HelloMD – $1 million. HelloMD, a service that uses telemedicine to connect people with doctors willing and able to prescribe medical marijuana, raised just over a million dollars via equity crowdfunding on SeedInvest. The raise includes $200,000 from SeedInvest itself via the platform’s “Selections Fund”. At the time of the announcement, the round was not complete, so the company could end up raising significantly more.
HealthReveal – $500 thousand. Healthcare technology company HealthReveal, which equips payers and providers with data analytics and remote monitoring to ensure patients receive guideline-directed medical care, added another $500,000 to its Series A funding with an investment from Northwell Ventures. Along with the $10.8 million HealthReveal raised a few months ago(led by GE Ventures, Greycroft Partners and Flare Capital Partners), the new funding brings the company’s total funding to date at $11.3 million.
Impathiq – $350 thousand. Winston-Salem, North Carolina-based Impathiq, which makes a data informatics platform that allows hospitals and health systems to integrate new apps and programs into their electronic medical records in accordance with interoperability standards, has announced it raised $350,000 in seed funding and has saved hospitals over $3 million in the year since its launch.
NarrativeDx – undisclosed. Austin, Texas-based NarrativeDx raised an undisclosed Series A round, led by LiveOak Venture Partners, Cultivation Capital and HealthX Ventures. The company uses AI and natural language processing to analyze patient feedback and return suggestions on how a healthcare organization can improve the patient experience.